<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bioinformation</journal-id><journal-id journal-id-type="publisher-id">Bioinformation</journal-id><journal-title>Bioinformation</journal-title><issn pub-type="epub">0973-2063</issn><publisher><publisher-name>Biomedical Informatics Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19238253</article-id><article-id pub-id-type="pmc">2639690</article-id><article-id pub-id-type="publisher-id">002900032008</article-id><article-categories><subj-group subj-group-type="heading"><subject>Database</subject></subj-group></article-categories><title-group><article-title>FstSNP-HapMap3: a database of SNPs with high population differentiation for HapMap3</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Duan</surname><given-names>Shiwei</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cox</surname><given-names>Nancy Jean</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Dolan</surname><given-names>Mary Eileen</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref><xref ref-type="corresp" rid="COR1">*</xref></contrib><aff id="A1"><label>1</label>Section of Hematology/Oncology, Department of Medicine</aff><aff id="A2"><label>2</label>Department of Human Genetics</aff><aff id="A3"><label>3</label>Committee on Clinical Pharmacology and Pharmacogenomics</aff><aff id="A4"><label>4</label>Cancer Research Center, The University of Chicago, IL 60637, USA</aff></contrib-group><author-notes><corresp id="COR1"><label>*</label>Mary Eileen Dolan: <email>edolan@medicine.bsd.uchicago.edu</email>; Phone: 773 702 4441; Fax: 773 702 0963</corresp></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>9</day><month>11</month><year>2008</year></pub-date><volume>3</volume><issue>3</issue><fpage>139</fpage><lpage>141</lpage><history><date date-type="received"><day>16</day><month>9</month><year>2008</year></date><date date-type="rev-recd"><day>10</day><month>10</month><year>2008</year></date><date date-type="accepted"><day>15</day><month>10</month><year>2008</year></date></history><permissions><copyright-statement>&#x000a9; 2007 Biomedical Informatics Publishing Group</copyright-statement><copyright-year>2007</copyright-year><license license-type="open-access"><p>This is an open-access article, which permits unrestricted use, distribution, and reproduction in any medium, 		for non-commercial purposes, provided the original author and source are credited.</p></license></permissions><abstract><p>					The International HapMap Project has recently made available genotypes and frequency data for phase 3 (NCBI build 36, 			dbSNPb129) of the HapMap providing an enriched genotype dataset for approximately 1.6 million single nucleotide 			polymorphisms (SNPs) from 1,115 individuals with ancestry from parts of Africa, Asia, Europe, North America and Mexico. 			In the present study, we aim to facilitate pharmacogenetics studies by providing a database of SNPs with high population 			differentiation through a genomewide test on allele frequency variation among 11 HapMap3 samples. Common SNPs with minor 			allele frequency greater than 5&#x000a2; from each of 11 HapMap3 samples were included in the present analysis. The population            differentiation is measured in terms of fixation index (Fst), and the SNPs with Fst values over 0.5 were defined as highly            differentiated SNPs. Our tests were carried out between all pairs of the 11 HapMap3 samples or among subgroups with the same            continental ancestries. Altogether we carried out 64 genomewide Fst tests and identified 28,215 highly differentiated SNPs             for 49 different combinations of HapMap3 samples in the current database.</p><sec id="sble"><title>Availability</title><p><ext-link ext-link-type="uri" xlink:href="http://FstSNP-hapmap3.googlecode.com/">           http://FstSNP-hapmap3.googlecode.com/</ext-link></p></sec></abstract><kwd-group><kwd>database</kwd><kwd>HapMap3</kwd><kwd>SNP</kwd><kwd>population differentiation</kwd><kwd>Fst</kwd><kwd>human genome</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>Background</title><p>With a public dataset of both genotypes and inferred haplotypes for millions of SNPs in ethnically diversesamples, the International HapMap Project [<xref ref-type="bibr" rid="R01">1</xref>] has provided alandscape of the human genome that enables genetic scientists to compare their genetic variant results with that ofa reference. The vast information from the International HapMap Project has significantly driven the development ofmore efficient statistical tools for high-throughput analysis of large genetic data sets [<xref ref-type="bibr" rid="R02">2</xref>] and enhanced our knowledge of population genetics [<xref ref-type="bibr" rid="R03">3</xref>&#x02013;<xref ref-type="bibr" rid="R04">4</xref>]. Given that the HapMap samples are Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCLs) that can be purchased [<xref ref-type="bibr" rid="R05">5</xref>], researchers can perform integrated analysis that includes genetic variation, gene expression [<xref ref-type="bibr" rid="R06">6</xref>&#x02013;<xref ref-type="bibr" rid="R09">9</xref>], gene transcript isoforms [<xref ref-type="bibr" rid="R10">10</xref>] and sensitivity to drugs [<xref ref-type="bibr" rid="R11">11</xref>&#x02013;<xref ref-type="bibr" rid="R15">15</xref>].</p><p>HapMap3 enhances the initial HapMap samples with 1,115 individual samples collected from 11 populations around theworld, thus providing more diversity. The HapMap3 includes samples from individuals of African, Asian, European andMexican descent residing in various locations. Therefore, it has become an ideal resource to study genotype-phenotyperelationships with cellular phenotypes.</p><p>In this analysis, we compare the genotypic frequencies of over 1 million SNPs among the samples. We hypothesize thatthe list of candidate SNPs, which have significantly different allele frequency distributions among the diverse samples,will facilitate studies attempting to correlate genotype with cellular phenotypes such as pharmacogenomics, and alertinvestigators to SNPs that might contribute disproportionately to substructure within more heterogeneous samples.</p></sec><sec sec-type="methods" id="s2"><title>Methodology</title><sec id="s2a"><title>HapMap3 genotypic data and SNP function classes</title><p>The genotypic data of 1,115 individuals from 11 population samples were downloaded from the International HapMapProject website (Phase III, release 1). Two samples NA18955, NA18962 in the CHB group actually belong to theJPT sample set, and thus were dropped out of the analysis. In the current study, the tested population panel focused only onthe 931 unrelated individuals comprised of Gujarati Indians in Houston, Texas (GIH, n = 83), individuals of Mexicanancestry in Los Angeles, California (MEX, n = 47) and individuals of African ancestry from the Southwest USA(ASW, n = 47), Luhya in Webuye, Kenya (LWK, n = 83), Maasai in Kinyawa, Kenya (MKK, n = 143), Yoruba inIbadan, Nigeria (YRI, n = 108), Han Chinese from Beijing, China (CHB, n = 80), Chinese from metropolitan Denver,Colorado (CHD, n = 70), Japanese from Tokyo, Japan (JPT, n= 82); Utah residents with Northern and Western Europeanancestry from the CEPH collection (CEU, n = 111), and Tuscans from Italy (TSI, n = 77). Of note, two samples(NA18955, NA18962) included in the CHB group belong to JPT. Five groups of samples (ASW, CEU, MEX, MKK andYRI) are familial samples; and the rest are unrelated samples. A total of 1,614,792 polymorphic SNPs were genotyped inthe HapMap3 Project. The number of shared SNPs ranges from 1,047,055 to 1,487,361 for the pair-wise combinationsof the 11 HapMap3 population samples (<xref ref-type="fig" rid="F1">Figure 1</xref>). Using the same reference allele of a SNP, we calculated the allele frequencies across all the populations.</p></sec><sec id="s2b"><title>Fst calculation</title><p>Fst, a metric representation of the effect of population subdivision, was estimated according to Wright'sapproximate formula, <italic>Fst = (H<sub>T</sub> &#x02212; H<sub>S</sub>) / H<sub>T</sub></italic> where H<sub>T</sub> represents expected heterozygosity per locus of the totalpopulation and H<sub>S</sub> represents expected heterozygosity of a subpopulation [<xref ref-type="bibr" rid="R16">16</xref>]. An Fst value was calculated for each SNP of interest with allele frequencies estimated from the unrelated individuals in each population. We calculated Fst values for only SNPs with minor allele frequencies greater than 5&#x000a2; in each of the HapMap3 samples.</p></sec><sec id="s2c"><title>Dataset</title><p>The dataset [<xref ref-type="bibr" rid="R17">17</xref>] contains all SNPs with Fst value over 0.5from the tests between any two of the 11 HapMap3 samples. There are 28,215 common SNPs with high populationdifferentiation observed for at least 1 of 49 different combinations of HapMap3 population samples in thedatabases.</p></sec><sec id="s2d"><title>Development</title><p>The genotypes of approximately 1.6 million SNPs were downloaded from the International HapMap Project (HapMap3, release 1). Fst was evaluated for over 1 million SNPs for each of the 55 paired combinations from the 11 HapMap3 samples, followed by rearrangement into five distinct groups defined by historical geographic ancestry (African, Asian, European, MEX and GIH) (<xref ref-type="fig" rid="F1">Figure 1</xref>). The Fst test was evaluated again among the combinations of the fivegeographical defined groups. Altogether there are 64 genomewide Fst tests for the HapMap3 samples. SNPs with high population differentiation (Fst &#x0003e; 0.5) were categorized into two major classes: genic and nongenic SNPs. The genicSNPs were further divided into six function classes including intron, UTR (utr-3 or utr-5), locus region (near-gene-3 ornear-gene-5), splice site, coding synonymous or nonsynonymous based on the annotation in the NCBI dbSNP129 database. The SNP annotation was added as a separate column to facilitate additional applications in the future.</p></sec><sec id="s2e"><title>Database content</title><p>This database [<xref ref-type="bibr" rid="R17">17</xref>] provides 115, 212 entries of 28,215 SNPs with high differentiation among 48 different combinations of the HapMap3 samples. There are six columns for the database as follows: SNP, SNP_CHR (SNP Chromosome), SNP_POSI (SNP position in dbSNP129), Fst value, Tested_Populations and DbSNP129_Class. The number of the entries in each group ranges from 3 for GIH_TSI group to 10,416 for JPT_YRI group.</p></sec><sec id="s2f"><title>Database usage</title><p>The users can download the FstSNP_HapMap3 [<xref ref-type="bibr" rid="R17">17</xref>] and thenquery the database by the conditions of genomic regions or a list of SNPs or SNP Class.</p></sec></sec><sec id="s3"><title>Caveats</title><p>The Fst test was evaluated in the HapMap3 population samples, some of which have relatively small sample size(e.g. 47 individuals in ASW and MEX). Furthermore, we note that SNPs included in HapMap3 are subject to a numberof ascertainment biases; thus, these SNPs cannot be considered as representative of Fst values that might becalculated for all common variants.</p></sec></body><back><ack><p>This Pharmacogenetics of Anticancer Agents Research (PAAR) Group (<ext-link ext-link-type="uri" xlink:href="http://pharmacogenetics.org">http://pharmacogenetics.org</ext-link>) study was supported by the NIH/NIGMS grant U01GM61393.</p></ack><ref-list><title>References</title><ref id="R01"><label>1</label><citation citation-type="web"><ext-link ext-link-type="uri" xlink:href="http://www.hapmap.org">http://www.hapmap.org</ext-link></citation></ref><ref id="R02"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><source>Am J Hum Genet</source><year>2006</year><volume>79</volume><fpage>628</fpage><pub-id pub-id-type="pmid">16960799</pub-id></citation></ref><ref id="R03"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sabeti</surname><given-names>PC</given-names></name><etal/></person-group><source>Nature</source><year>2007</year><volume>449</volume><fpage>913</fpage><pub-id pub-id-type="pmid">1794313</pub-id></citation></ref><ref id="R04"><label>4</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Barreiro</surname><given-names>LB</given-names></name><etal/></person-group><source>Nat Genet</source><year>2008</year><volume>40</volume><fpage>340</fpage><pub-id pub-id-type="pmid">18246066</pub-id></citation></ref><ref id="R05"><label>5</label><citation citation-type="web"><ext-link ext-link-type="uri" xlink:href="http://www.coriell.org">http://www.coriell.org</ext-link></citation></ref><ref id="R06"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stranger</surname><given-names>BE</given-names></name><etal/></person-group><source>Nat Genet</source><year>2007</year><volume>39</volume><fpage>1217</fpage><pub-id pub-id-type="pmid">17873874</pub-id></citation></ref><ref id="R07"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group><source>Am J Hum Genet</source><year>2008</year><volume>82</volume><fpage>631</fpage><pub-id pub-id-type="pmid">18313023</pub-id></citation></ref><ref id="R08"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>S</given-names></name><etal/></person-group><source>Am J Hum Genet</source><year>2008</year><volume>82</volume><fpage>1101</fpage><pub-id pub-id-type="pmid">18439551</pub-id></citation></ref><ref id="R09"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>RS</given-names></name><etal/></person-group><source>Pharmacogenet Genomics</source><year>2008</year><volume>18</volume><fpage>545</fpage><pub-id pub-id-type="pmid">18496134</pub-id></citation></ref><ref id="R10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname><given-names>T</given-names></name><etal/></person-group><source>Nat Genet</source><year>2008</year><volume>40</volume><fpage>225</fpage><pub-id pub-id-type="pmid">18193047</pub-id></citation></ref><ref id="R11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>S</given-names></name><etal/></person-group><source>Cancer Res</source><year>2007</year><volume>67</volume><fpage>5425</fpage><pub-id pub-id-type="pmid">17545624</pub-id></citation></ref><ref id="R12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>RS</given-names></name><etal/></person-group><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>9758</fpage><pub-id pub-id-type="pmid">17537913</pub-id></citation></ref><ref id="R13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>RS</given-names></name><etal/></person-group><source>Am J Hum Genet</source><year>2007</year><volume>81</volume><fpage>427</fpage><pub-id pub-id-type="pmid">17701890</pub-id></citation></ref><ref id="R14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>SJ</given-names></name><etal/></person-group><source>Pharmacogenet Genomics</source><year>2008</year><volume>18</volume><fpage>253</fpage><pub-id pub-id-type="pmid">18300947</pub-id></citation></ref><ref id="R15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>RS</given-names></name><etal/></person-group><source>Cancer Res</source><year>2008</year><volume>68</volume><fpage>3161</fpage><pub-id pub-id-type="pmid">18451141</pub-id></citation></ref><ref id="R16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>S</given-names></name></person-group><source>Nature</source><year>1950</year><volume>166</volume><fpage>247</fpage><pub-id pub-id-type="pmid">15439261</pub-id></citation></ref><ref id="R17"><label>17</label><citation citation-type="web"><ext-link ext-link-type="uri" xlink:href="http://FstSNP-hapmap3.googlecode.com">     http://FstSNP-hapmap3.googlecode.com</ext-link></citation></ref></ref-list></back><floats-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p>The diagram for the construction of FstSNP_HapMap3</p></caption><graphic xlink:href="97320630003139F1"/></fig></floats-wrap></article>